XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of segment reporting
                     
   Hospitality  Disinfectant  Corporate  Total
Balance sheet at September 30, 2023                     
Assets   $12,041,295   $58,169,140   $1,380,197   $71,590,632 
Liabilities   $10,731,810   $29,656,765   $8,446,856   $48,835,431 
Balance sheet at December 31, 2022                     
Assets   $9,638,828   $19,831,097   $3,257,502   $32,727,427 
Liabilities   $10,666,643   $1,545,217   $3,281,672   $15,493,532 

   Hospitality  Disinfectant  Corporate  Total
Income Statement for the three months ended September 30, 2023:                    
Net Sales  $5,715,354   $5,730,694   $—     $11,446,048 
Cost of Goods Sold  $4,454,534   $4,336,230   $—     $8,790,764 
Research and development  $—     $91,085   $—     $91,085 
Stock based compensation  $57,821   $34,188   $139,845   $231,854 
Selling, General and Administrative
Expenses
  $1,123,073   $3,130,810   $528,251   $4,782,134 
Income Statement for the three months ended September 30, 2022:                    
Net Sales  $4,282,030   $1,593,581   $—     $5,875,611 
Cost of Goods Sold  $4,117,717   $919,280   $—     $5,036,997 
Research and development  $—     $93,522   $—     $93,522 
Stock based compensation  $30,149   $37,800   $44,502   $112,451 
Selling, General and Administrative
Expenses
  $929,992   $1,893,211   $522,364   $3,345,567 
Income Statement for the nine months ended September 30, 2023:                    
Net Sales  $16,944,409   $15,999,808   $—     $32,944,217 
Cost of Goods Sold  $13,895,604   $12,061,249   $—     $25,956,853 
Research and development  $—     $460,588   $—     $460,588 
Stock based compensation  $172,495   $104,552   $339,613   $616,660 
Selling, General and Administrative
Expenses
  $3,362,775   $9,002,786   $2,588,265   $14,953,826 
Income Statement for the nine months ended September 30, 2022:                    
Net Sales  $9,860,392   $5,278,955   $—     $15,139,347 
Cost of Goods Sold  $8,971,628   $2,876,214   $—     $11,847,842 
Research and development  $—     $234,885   $—     $234,885 
Stock based compensation  $151,679   $99,733   $308,568   $559,980 
Selling, General and Administrative
Expenses
  $2,784,540   $5,711,495   $1,581,523   $10,077,558 
Loss on impairment of goodwill  $—     $1,138,203   $—     $1,138,203